It is a healthcare private not for profit company based in Pune, Maharashtra, India, established in 2012.
2012 | Pune, Maharashtra, India | ActiveDecimate-C Anticancer Foundation, a active private not for profit company, was established on 27 December 2012 in Pune, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85100PN2012NPL145805. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rhucha Rahul Dasare (Director), Prerana Prasad Patil (Director), Arundhati Anil Ranade (Director). Past directors included Rhucha Rahul Dasare, Prerana Prasad Patil, Anantbhushan Anil Ranade. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Office No. 8,4Th Floor, Amit Complex, Opp - New English School, Tilak Road, Sadashiv, Peth, Pune, Maharashtra, 411030.
U85100PN2012NPL145805
145805
27 December 2012
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Decimate-C Anticancer Foundation — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rhucha Rahul Dasare | Director | 18 Dec 2019 | Current |
| Prerana Prasad Patil | Director | 18 Dec 2019 | Current |
| Arundhati Anil Ranade | Director | 17 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2020 | Past |
| Pramod Abcsdd | Director | 16 Nov 2013 | Past |
| Pramod Abcsdd | Director | 30 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 30 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Decimate-C Anticancer Foundation, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.11% decrease. The company also saw a substantial fall in profitability, with a 405.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Decimate-C Anticancer Foundation had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Decimate-C Anticancer Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Decimate-C Anticancer Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decimate-C Anticancer Foundation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Decimate-C Anticancer Foundation last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Decimate-C Anticancer Foundation has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was recorded as a recent event.
The activity Rhucha Rahul Dasare was appointed as a Director was appointed as a Director on 18 Dec 2019 & has been associated with this company since 6 years . was completed.
Prerana Prasad Patil was appointed as a Director was appointed as a Director on 18 Dec 2019 & has been associated with this company since 6 years . was recorded as a recent event.
Progress on Arundhati Anil Ranade was appointed as a Director was appointed as a Director on 17 Jan 2017 & has been associated with this company since 8 years 11 months . was documented.
Progress on Decimate-C Anticancer Foundation was registered on 27 Dec 2012 with Roc Pune & aged 12 years 11 months as per MCA records. was documented.
The CIN of Decimate-C Anticancer Foundation is U85100PN2012NPL145805.
Decimate-C Anticancer Foundation is headquartered at Office No. 8,4Th Floor, Amit Complex, Opp - New English School, Tilak Road, Sadashiv, Peth, Pune, Maharashtra, 411030.
Decimate-C Anticancer Foundation was incorporated on 27 December 2012.
The current directors of Decimate-C Anticancer Foundation are
The primary industry of Decimate-C Anticancer Foundation is Hospital And Medical Care.
Decimate-C Anticancer Foundation is unlisted.
The authorized capital of Decimate-C Anticancer Foundation is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Decimate-C Anticancer Foundation is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX